Skip to content
Review Open access

EP1222 - ECE_2023 - Multifocal paraganglioma in Von Hippel-Lindau syndrome: a diagnostic conundrum unfolded through multimodal investigation

Aug 2026 · European Journal of Endocrinology · Vol 195 · 0 citations

TL;DR

A 42-year-old female with no personal or family history of PPGL presented with flank pain and urinary symptoms, and further evaluation revealed a unifying diagnosis of Von Hippel-Lindau (VHL) syndrome, a rare autosomal dominant disorder associated with multifocal neuroendocrine tumours.

Abstract

We present a diagnostically complex case of multifocal phaeochromocytoma and paraganglioma (PPGL), initially suggestive of metastatic disease. Further evaluation revealed a unifying diagnosis of Von Hippel-Lindau (VHL) syndrome. A 42-year-old female with no personal or family history of PPGL presented with flank pain and urinary symptoms. CT imaging revealed a 4.3 cm atypical right adrenal lesion. Endocrinology review noted episodic hypertension, sweating, and palpitations. Biochemistry showed elevated plasma normetadrenaline (5.51 nmol/L) and metadrenaline (0.34 nmol/L). Alpha blockade with doxazosin was initiated. Functional imaging (MIBG, FDG PET, somatostatin receptor scintigraphy) confirmed pheochromocytoma. Additional lesions included a 1 cm left para-aortic mass, a non-avid left adrenal nodule (likely adenoma), and a right retrothyroidal neck lesion—all showing uptake on functional imaging. Thyroid ultrasound revealed a U5 lesion, raising concern for metastatic PPGL. Cytology of the neck lesion confirmed a head and neck paraganglioma. Further imaging identified benign liver haemangioma and bilateral renal parapelvic cysts, prompting genetic testing. Genetic analysis revealed a heterozygous pathogenic VHL mutation: NM_000551.3:c.250G>A; p.(Val84Met), confirming the diagnosis of VHL syndrome. A heterozygous pathogenic VHL mutation was found, making multifocal PPGL more likely. However, the distribution of neuroendocrine lesions was still concerning for metastatic PPGL. Patient underwent uncomplicated laparoscopic right adrenalectomy. Histology confirmed pheochromocytoma with classic Zellballen architecture, chromogranin and synaptophysin positivity, and a low Ki-67 index (<2%), consistent with benign behaviour. Persistently elevated normetanephrines led to excision of the left para-aortic lesion, with histology confirming paraganglioma and biochemical normalization. Surveillance imaging remains unremarkable, excluding metastatic disease. VHL syndrome is a rare autosomal dominant disorder associated with multifocal neuroendocrine tumours. Though sporadic VHL mutations are rare, clinical awareness can aid diagnosis. PPGL in VHL mostly presents as benign multifocal disease but in rare cases can be metastatic.

Read PDF

Similar papers

Open access Aug 2026

From obstructive uropathy to syndromic suspicion: a case of multiglandular primary hyperparathyroidism and pancreatic nodule mimicking multiple endocrine neoplasia type 1

Multiple endocrine neoplasia type 1 (MEN-1) is an autosomal dominant disorder characterized by synchronous or metachronous tumor development within the parathyroid glands, enteropancreatic neuroendocrine framework, and anterior pituitary. A 48-year-old female presented with severe bilateral loin pain and anuria lasting...

Vinodhini Duraisamy, L. S., Manivannan Dhanraj et al. · 0 citations
Review Open access Sep 2026

Calcitonin-negative 'MTC-like' thyroid paraganglioma revealing an SDHD-related hereditary paraganglioma syndrome: functional confirmation of a non-canonical splice-site variant.

INTRODUCTION Primary thyroid paraganglioma (TPGL) is a rare mimic of medullary thyroid carcinoma (MTC). We report an SDHD-related TPGL caused by a non-canonical splice-region variant. CASE PRESENTATION A 36-year-old woman underwent thyroidectomy for a 20 mm EU-TIRADS 4 Bethesda III thyroid nodule with normal serum ca...

G. Effraimidis, V. Trachana, Evmorfia Tzagkaraki et al. · 0 citations
Case report Open access Sep 2026

MRI assessment of locoregional extent in a Buschke–Löwenstein tumor with histopathologically confirmed malignant transformation: A case report

The Buschke-Löwenstein tumor (BLT), also designated giant condyloma acuminatum, represents a rare anogenital neoplasm of intermediate biological behavior, occupying a nosological boundary between benign condylomatous disease and invasive squamous cell carcinoma (SCC). Its malignant transformation potential, estimated b...

Ibtissam El Bqaq, Zayneb Iraqi Houssaini, Ayoub Ajerame et al. · 0 citations
Case report Aug 2026

Molecular stability overrides size in giant pediatric pheochromocytoma

Abstract Objectives Pheochromocytoma is a rare but potentially life-threatening tumor in children, and its diagnosis may be challenging due to variable clinical presentations. We aimed to describe the diagnostic process and clinical outcomes of a child with a giant pheochromocytoma presenting with severe hypertension a...

E. Şimşek, Hüseyin İlhan, Murat Yilmaz et al. · 0 citations
Review Open access Sep 2026

STK11 adnexal tumor mimicking a female adnexal tumor of probable Wolffian origin (FATWO) associated with Peutz-Jeghers syndrome: A brief review.

ABSTRACT Lately, STK11 adnexal tumors have been described in patients with Peutz-Jeghers syndrome (PJS), showing overlap with other adnexal tumors, especially female adnexal tumor of probable Wolffian origin (FATWO). To date, there is no documentation of this tumor from the Indian subcontinent. A 25-year-old female wit...

Musheera Aziz, B. Rekhi, S. Gowrishankar et al. · 0 citations
Review Aug 2026

[Composite pheochromocytoma with ganglioneuroblastoma in an adult: a case report and literature review].

Com composite PCC with GNB in adults is exceedingly rare and its clinical, biochemical, and imaging manifestations frequently overlap with those of conventional PCC, rendering definitive diagnosis dependent on histopathological examination.

Y. Y. Song, J.-H. Li, Y.-Q. Yin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.